BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25598150)

  • 1. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.
    Petrosino S; Schiano Moriello A; Cerrato S; Fusco M; Puigdemont A; De Petrocellis L; Di Marzo V
    Br J Pharmacol; 2016 Apr; 173(7):1154-62. PubMed ID: 25598150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
    Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
    Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
    Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
    Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
    Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
    Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
    Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
    Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
    J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS; Barrett DA; Randall MD
    Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
    Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
    Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
    Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
    Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
    Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons.
    De Petrocellis L; Schiano Moriello A; Imperatore R; Cristino L; Starowicz K; Di Marzo V
    Br J Pharmacol; 2012 Dec; 167(8):1643-51. PubMed ID: 22861649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
    ; De Filippis D; D'Amico A; Cipriano M; Petrosino S; Orlando P; Di Marzo V; Iuvone T
    Pharmacol Res; 2010 Apr; 61(4):321-8. PubMed ID: 19931394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
    Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
    Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
    Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
    Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
    Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
    Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.